ACXP
ACXP
NASDAQ · Biotechnology

Acurx Pharmaceuticals Inc

$2.19
+0.13 (+6.31%)
As of Feb 8, 2:32 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 850.6K 846.2K 822.4K
Net Income -189,460 -228,334 -201,883
EPS
Profit Margin -22.3% -27.0% -24.6%
Rev Growth +3.9% -4.1% +22.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.74M 2.37M 2.87M
Total Equity 4.04M 3.87M 3.90M
D/E Ratio 0.68 0.61 0.74
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -320,116 -324,230 -315,475
Free Cash Flow -189,627 -182,540 -129,892